1. Home
  2. RBCAA vs TRVI Comparison

RBCAA vs TRVI Comparison

Compare RBCAA & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Republic Bancorp Inc.

RBCAA

Republic Bancorp Inc.

N/A

Current Price

$67.35

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

N/A

Current Price

$11.80

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RBCAA
TRVI
Founded
1974
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
RBCAA
TRVI
Price
$67.35
$11.80
Analyst Decision
Hold
Strong Buy
Analyst Count
1
12
Target Price
N/A
$20.38
AVG Volume (30 Days)
29.9K
1.2M
Earning Date
05-01-2026
01-01-0001
Dividend Yield
2.62%
N/A
EPS Growth
N/A
N/A
EPS
0.77
N/A
Revenue
$417,495,000.00
N/A
Revenue This Year
$3.93
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$88.83
N/A
Revenue Growth
8.50
N/A
52 Week Low
$56.79
$4.85
52 Week High
$78.00
$14.39

Technical Indicators

Market Signals
Indicator
RBCAA
TRVI
Relative Strength Index (RSI) 35.06 51.36
Support Level $64.16 $10.04
Resistance Level $72.98 $12.11
Average True Range (ATR) 2.20 0.70
MACD -0.38 0.17
Stochastic Oscillator 10.56 52.82

Price Performance

Historical Comparison
RBCAA
TRVI

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans and receipt and payment of federal.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: